ScoreWhy is IRadimed Corp. ?
1
High Management Efficiency with a high ROE of 17.02%
2
Company has a low Debt to Equity ratio (avg) at times
3
Healthy long term growth as Operating profit has grown by an annual rate 56.09%
4
The company has declared Positive results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 19.4 MM
- NET SALES(Q) Highest at USD 20.41 MM
- RAW MATERIAL COST(Y) Fallen by -0.04% (YoY)
5
With ROE of 21.97%, it has a attractive valuation with a 8.54 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 72.75%, its profits have risen by 10.4% ; the PEG ratio of the company is 4
6
High Institutional Holdings at 64.9%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
7
Market Beating performance in long term as well as near term
- Along with generating 72.75% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to IRadimed Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is IRadimed Corp. for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
IRadimed Corp.
75.09%
3.25
36.00%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
16.40%
EBIT Growth (5y)
56.09%
EBIT to Interest (avg)
14.28
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.56
Sales to Capital Employed (avg)
0.86
Tax Ratio
20.79%
Dividend Payout Ratio
29.91%
Pledged Shares
0
Institutional Holding
64.90%
ROCE (avg)
58.93%
ROE (avg)
17.02%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
39
Industry P/E
Price to Book Value
8.54
EV to EBIT
31.75
EV to EBITDA
30.68
EV to Capital Employed
18.07
EV to Sales
9.57
PEG Ratio
3.97
Dividend Yield
0.79%
ROCE (Latest)
56.93%
ROE (Latest)
21.97%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 19.4 MM
NET SALES(Q)
Highest at USD 20.41 MM
RAW MATERIAL COST(Y)
Fallen by -0.04% (YoY
DIVIDEND PER SHARE(HY)
Highest at USD 0
OPERATING PROFIT(Q)
Highest at USD 7.38 MM
OPERATING PROFIT MARGIN(Q)
Highest at 36.16 %
PRE-TAX PROFIT(Q)
Highest at USD 7.33 MM
NET PROFIT(Q)
Highest at USD 5.77 MM
EPS(Q)
Highest at USD 0.45
-4What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 0 times
DEBT-EQUITY RATIO
(HY)
Highest at -56.2 %
DEBTORS TURNOVER RATIO(HY)
Lowest at 0 times
Here's what is working for IRadimed Corp.
Operating Cash Flow
Highest at USD 19.4 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 20.41 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Operating Profit
Highest at USD 7.38 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 36.16 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 7.33 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 5.77 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 0.45
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Dividend per share
Highest at USD 0
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (USD)
Raw Material Cost
Fallen by -0.04% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for IRadimed Corp.
Inventory Turnover Ratio
Lowest at 0 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debt-Equity Ratio
Highest at -56.2 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
